<p>ORBUSNEICH (06929.HK) announced its full-year results for the year ended last December, with a revenue of USD 180 million, an increase of 10% year-on-year. The net profit was HKD 41.899 million, up 5.5% year-on-year; earnings per share were HKD 0.0509. A final dividend of HKD 0.12 was declared, compared to HKD 0.10 in the same period last year</p>

06929

516500

516930

159837

562600

159849

159883

159898

<p>ORBUSNEICH announced its full-year results for the year ended December last year, with a revenue of USD 180 million, an increase of 10% year-on-year. The net profit was HKD 41.899 million, an increase of 5.5% year-on-year; earnings per share were HKD 5.09 cents. A final dividend of HKD 0.12 was declared, compared to HKD 0.10 in the same period last year</p>

AASTOCKS

ORBUSNEICH

ChinaAMC CSI Biotechnology Theme ETF

Minsheng Royal CSI Biotechnology Theme ETF

E Fund CSI Biotechnology Theme ETF

ChinaAMC CSI All Share Health Care Devices ETF

China Merchants CSI Biotechnology Theme ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

In the "Performance" report, ORBUSNEICH's annual net profit is USD 41.899 million, an increase of 5.5%, with a final dividend of HKD 0.12